Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study

Jasmine Levine, Rahib K. Islam, Lillian Mo, Brian S. Kim, Jordan Talia, Shari R. Lipner, Benjamin Ungar

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Allergy: European Journal of Allergy and Clinical Immunology
DOIs	https://doi.org/10.1111/all.16637
State	Accepted/In press - 2025

Keywords

@article{d8d7162fbbe14a24874b75bd0445d502,

title = "Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study",

keywords = "allergy, atopic dermatitis, dupilumab, gastrointestinal symptoms, irritable bowel syndrome, mast cell dysfunction",

author = "Jasmine Levine and Islam, \{Rahib K.\} and Lillian Mo and Kim, \{Brian S.\} and Jordan Talia and Lipner, \{Shari R.\} and Benjamin Ungar",

year = "2025",

doi = "10.1111/all.16637",

language = "English",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk

T2 - A Real-World Cohort Study

AU - Levine, Jasmine

AU - Islam, Rahib K.

AU - Mo, Lillian

AU - Kim, Brian S.

AU - Talia, Jordan

AU - Lipner, Shari R.

AU - Ungar, Benjamin

PY - 2025

Y1 - 2025

KW - allergy

KW - atopic dermatitis

KW - dupilumab

KW - gastrointestinal symptoms

KW - irritable bowel syndrome

KW - mast cell dysfunction

UR - https://www.scopus.com/pages/publications/105008893054

U2 - 10.1111/all.16637

DO - 10.1111/all.16637

M3 - Letter

AN - SCOPUS:105008893054

SN - 0105-4538

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

ER -